Lara Meisner has sold VRDN and made no open-market buys since Nov 2022
General Counsel at Viridian Therapeutics, Inc.
SEC CIK 0001883986 · Filings on SEC.gov ↗
$0Bought
$2.5MSold
NoneLast buy
Every filing
8 filings since Nov 2022, newest first
VRDNSell
Viridian Therapeutics, Inc.de
General Counsel
$64K−7.0%Jun 20
VRDNSell
Viridian Therapeutics, Inc.de
General Counsel
$186K−20.0%Jun 6
VRDNSell
Viridian Therapeutics, Inc.de
General Counsel and Secretary
$871K−100.0%Mar 10
VRDNSell
Viridian Therapeutics, Inc.de
General Counsel and Secretary
$244K−100.0%Jan 25
VRDNSell
Viridian Therapeutics, Inc.de
General Counsel and Secretary
$493K−100.0%Dec 22
VRDNSell
Viridian Therapeutics, Inc.de
General Counsel and Secretary
$45K−100.0%Dec 19
VRDNSell
Viridian Therapeutics, Inc.de
General Counsel and Secretary
$457K−100.0%Dec 14
VRDNSell
Viridian Therapeutics, Inc.de
General Counsel and Secretary
$179K−100.0%Nov 16
Filings come from SEC EDGAR. Not investment advice.